NEW YORK (Reuters Health) – Just 38% of patients with suspected cardiac disease are found to have obstructive coronary disease on elective cardiac catheterization, new research shows. This…
Andrew Charles, MD, Professor, Director of Headache Research and Treatment Program, UCLA David Geffen School of Medicine, discusses when to get a scan for a headache and the…
NEW YORK (Reuters Health) – Three weeks of hypofractionated whole-breast radiotherapy is at least as good as 5 weeks of standard radiotherapy after breast-conserving surgery for invasive cancer,…
NEW YORK (Reuters Health) – In women over 55, simple ovarian cysts are common, usually resolving or persisting without progression, according to data from the prospective Prostate, Lung,…
NEW YORK (Reuters Health) – Sonographic surveillance of newborns with mild hip dysplasia can reduce the need for early abduction splinting without increasing the risk of persistent or…
NEW YORK (Reuters Health) – In patients with middle cerebral artery occlusion, an alteplase dosage of 0.6 mg/kg IV is comparable to a 0.9 mg/kg dosage for achieving…
NEW YORK (Reuters Health) – High-dose atorvastatin does not protect against contrast-induced nephropathy (CIN) in patients with kidney disease, Italian researchers report. “Statins have recently been proposed for…
NEW YORK (Reuters Health) – Endovascular treatment of intracranial aneurysms 3 mm or smaller in diameter is difficult and risky — but it’s successful in over 90% of…
NEW YORK (Reuters Health) – Repeat cardiac catheterizations and use of vascular closure devices do not reduce femoral artery size at the puncture site or promote progression of…
NEW YORK (Reuters Health) – A substantial proportion of women with cervical cancer who receive curative-intent radiotherapy will soon develop pelvic fractures, clinicians from the University of Texas…